DSX Diana Shipping Inc. c/o Diana Shipping Services S.A.
Price Chart
Executive Summary
Diana Shipping increased its hostile tender offer for Genco Shipping & Trading to $24.80/share all-cash, but Genco's board unanimously rejected it for the third time without substantive engagement. Diana is now escalating its proxy fight, urging Genco shareholders to vote for its six independent director nominees at the June 18 annual meeting to force a deal.
Key Financial Metrics
Actionable Insight
Track Genco shareholder vote outcomes at June 18 annual meeting — if Diana wins even one board seat, deal probability surges. Also monitor tender offer acceptance rate and any Genco poison pill amendments. DSX may re-rate on increased likelihood of capturing GNK's NAV discount via acquisition.
Key Facts
- Diana raised its offer to $24.80/share all-cash on May 27, 2026, from $23.50/share; Genco board rejected it without engaging.
- Diana is the largest Genco shareholder with a 14.4% stake (6,264,548 shares).
- Diana is running a proxy contest to elect six independent directors at Genco's June 18, 2026 annual meeting.
- Genco spent over $13M in defense costs plus an additional ~$2M on new 'inadequacy opinions' from Jefferies and Morgan Stanley.
- Diana's tender offer expires June 26, 2026; conditions include Genco signing a merger agreement and terminating its poison pill.
- Diana claims its offers reflect nearly 100% of NAV per VesselsValue, consistent with Genco's own prior valuation methodology.
- Genco's shares have traded at an average 30% discount to NAV over the past five years.
Financial Impact
All-cash offer of $24.80/share values Genco at ~$1.08B based on ~43.5M fully diluted shares; Diana funds with $200M cash plus a $900M fully committed bridge loan.
Risk Factors
- Genco board may continue to resist, forcing Diana to raise the offer or walk away.
- Tender offer conditions require Genco's board to sign a merger agreement and terminate poison pill — both within Genco's control.
- Shipping rates downturn could reduce the strategic rationale for the deal.
- Regulatory or antitrust objections could delay or block the transaction.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3305512 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 4, 2026
2d ago
|
Press Release
| $2.39 awaiting T+1 | awaiting T+1 | — | $2.34 (−2.09%) |
|
Jun 2, 2026
4d ago
|
Press Release
| $2.39 $2.35 | ▼ −1.67% | ▼ −0.98% | $2.34 (−2.09%) |
|
May 28, 2026
9d ago
|
Press Release
| $2.47 $2.36 | ▼ −4.45% | ▼ −4.69% | $2.34 (−5.26%) |
|
May 27, 2026
10d ago
|
Press Release
| $2.52 $2.47 | ▼ −1.98% | ▼ −2.54% | $2.34 (−7.14%) |
|
May 15, 2026
22d ago
|
Press Release
| $2.67 $2.68 | ▲ +0.37% | ▲ +0.44% | $2.34 (−12.36%) |
|
May 14, 2026
23d ago
|
Press Release
| $2.76 $2.67 | ▼ −3.26% | ▼ −2.03% | $2.34 (−15.22%) |
|
May 4, 2026
4w ago
|
Press Release
| $2.59 $2.72 | ▲ +5.02% | ▲ +4.22% | $2.34 (−9.65%) |
|
Apr 29, 2026
5w ago
|
Press Release
| $2.47 $2.51 | ▲ +1.62% | ▲ +0.60% | $2.34 (−5.26%) |
|
Apr 24, 2026
6w ago
|
Press Release
| $2.44 $2.50 | ▲ +2.46% | ▲ +2.30% | $2.34 (−4.10%) |
|
Apr 13, 2026
7w ago
|
Press Release
| $2.52 $2.51 | ▼ −0.40% | ▼ −1.61% | $2.34 (−7.14%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access